Acurx Pharmaceuticals, Inc.
ACXPNASDAQHealthcareBiotechnology
As of Oct 16, 2026 close
- Market cap
- $4.98M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $1.15$7.81
- Volume (live)
- -
- Avg. volume (3M)
- 88.34K
Acurx Pharmaceuticals (ACXP) Stock Price & Financial Analysis
Acurx Pharmaceuticals Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $1.07 - $1.19 |
|---|---|
| 52-Week High | $7.81 |
| 52-Week Low | $1.15 |
| Open | $1.18 |
| Volume (last close) | 164.65K |
| Average Volume (3M) | 88.34K |
| 50-Day MA | $1.39 |
|---|---|
| 200-Day MA | $2.08 |
| 1-Year Change | −82.79% |
| Market Cap | 4.98M |
|---|---|
| Shares Outstanding | 4.26M |
| Price to Book (P/B) | 0.61 |
| EV/EBITDA | 0.75 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Acurx Pharmaceuticals at a Glance
As of the Oct 16, 2026 close, Acurx Pharmaceuticals (ACXP) has a market capitalization of $4.98M.
As of its latest reported balance sheet, it holds $10.66M in cash and securities against $0.00 of debt, a net cash position of $10.66M.
Acurx Pharmaceuticals does not currently pay a dividend.
The share price is down 82.8% over the past year. At $1.10 (the Oct 16, 2026 close) it sits near the bottom of its 52-week range of $1.15 to $7.81, below its 200-day moving average of $2.08.
Frequently Asked Questions About Acurx Pharmaceuticals
What is the current stock price for ACXP?
As of the Oct 16, 2026 close, ACXP stock trades at $1.10. The 52-week range is $1.15–$7.81, with a day range of $1.07–$1.19.
What is the P/E ratio for ACXP?
The P/E ratio (Price-to-Earnings) for ACXP is shown in the Key Statistics section. This valuation metric helps compare Acurx Pharmaceuticals, Inc. to industry peers.
Does ACXP pay dividends?
Acurx Pharmaceuticals does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for ACXP?
Analyst ratings and recommendations for ACXP are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of ACXP?
As of the Oct 16, 2026 close, Acurx Pharmaceuticals's market capitalization is $4.7M, classifying it as a micro-cap company. Acurx Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.